|
Marché Fermé -
Autres places de cotation
|
Après clôture 21:59:59 | |||
| 259,20 EUR | -5,71% |
|
258,85 | -0,14% |
Groupe UCB : Graphique Relationnel
Sociétés privées appartenant au même groupe que UCB
| Société | Dirigeant |
|---|---|
UCB Manufacturing Ireland Ltd.
 UCB Manufacturing Ireland Ltd. UCB Manufacturing Ireland Ltd. is part of UCB, an Irish biopharmaceutical company that discovers, develops, and delivers medicines for severe neurological, autoimmune, and rare diseases, including epilepsy, Parkinson ’ s disease, rheumatoid arthritis, hidradenitis suppurativa, myasthenia gravis, and other immune-mediated inflammatory conditions. The company is based in Ireland. | - |
UCB Fipar SA
 UCB Fipar SA Financial ConglomeratesFinance Functions as an investment holding company | - |
UCB Biopharma SRL
 UCB Biopharma SRL Medical DistributorsDistribution Services Wholesales pharmaceutical products and provides research & development on biotechnology | - |
UCB Finance NV | - |
UCB Pharma Ltd.
 UCB Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | - |
Ucb Belgium SA
 Ucb Belgium SA Pharmaceuticals: MajorHealth Technology Operates as a bio-pharmaceutical company, focusing on neurology and immunology | - |
UCB Ventures SA | - |
UCB Pharma SA (Belgium)
 UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | - |
UCB Pharma GmbH
 UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Karl-Werner Leffers |
UCB Ventures Belgium SA
 UCB Ventures Belgium SA Investment ManagersFinance Functions as a venture capital fund | - |
Zogenix International Ltd.
 Zogenix International Ltd. Pharmaceuticals: MajorHealth Technology Treats a chronic form of epilepsy | - |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
